Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAMSTA switched hypertension study
NL-OMON35041Phase 3Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of telmisartan and amlodipine in essential hypertension, sponsored by Boehringer Ingelheim. Started May 2010; status: active, not recruiting.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NL-OMON35041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35041.